Bio-Me today announced that it has successfully raised NOK 10 mill in a fully subscribed funding round. Both existing and new investors participated in the financing round, with new investors contributing to the majority of the capital....
Bio-Me and Siolta Therapeutics aim to develop and market predictive test for infants.
...
Bio-Me today announced that a new Board of Directors has been approved by the general assembly.
...
Runar Vige has taken on the role of Chief Clinical Officer. Runar brings more than 20 years of broad interdisciplinary experience working with companies like Pfizer, Pronova BioPharma, and BASF.
...
Bio-Me has received 2 million Euro in grants and public support from The Research Council of Norway to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments.
...
Bio-Me is one of the participants in a new Nordic project that will develop personalized treatment for IBD patients.
...
Bio-Me, a pioneer in rapid gut microbiome analysis is announcing the opening of its gut microbiome analysis service laboratory.
...
Bio-Me has entered into an agreement with one of the top ten consumer healthcare companies worldwide.
...
Dr. Morten Isaksen, CEO of Bio-Me, has been invited to present Bio-Me and its contribution to use of information from the gut microbiome in clinical settings.
...
Morten Isaksen, CEO of Bio-Me, is featured on LØRN, leading Norwegian technology blog and podcast service.
...
